Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
7218211
Reference Type
Journal Article
Title
Sacral nerve stimulation for treatment of fecal incontinence
Author(s)
Bader, FG; Franke, C; Keller, R; Mirow, L; Fischer, F; Bruch, HP; Roblick, UweJ; ,
Year
2007
Publisher
KARGER
Location
BASEL
Page Numbers
273-279
DOI
10.1159/000103987
Web of Science Id
WOS:000249907000009
Abstract
Fecal incontinence is common, distressing to the patient and socially incapacitating. Surgical treatment for fecal incontinence is often associated with disappointing results, especially when the patient presents with a functional and/or dynamic deficits without any structural defect. Thus, disappointing treatment results are often common. Sacral nerve stimulation (SNS) is an innovative, minimally invasive treatment that uses chronic low-level electrical stimulation of the sacral plexus to recruit residual physiological function. The exact mechanism of action is still unknown, but it is assumed that electric stimulation of the sacral nerves leads to neuromodulation as well as clinically beneficial effects to the pelvic floor, the sphincter complex and the distal color rectum. SNS is a multistep procedure, including acute and subchronic percutaneous nerve evaluation (PNE), followed by permanent stimulation provided by an implanted device. The predictive value of PNE is high, morbidity and surgical trauma are low. The screening phase provided by PNE makes this technique unique and offers an ideal instrument for patient selection. However, criteria for patient selection are evolving and are yet to be defined. Published data support the medium-term treatment success combined with improvement of quality of life in over 80% of patients. In patients in whom preceding therapies had failed, SNS is superior to other treatment options. Moreover, SNS seems to be more cost-effective in the short term. However, results for SNS in the treatment of fecal incontinence are promising, but need to be further validated in the long term. Heterogeneity of most study populations and varying causes of fecal incontinence makes data difficult to compare and do not allow a final statement of the impact of this technique. There is a clear need for prospective randomized trials to address these open questions.
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity